Search
Now showing items 1-3 of 3
Article
Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
(Nature Research, 2020)
Hepatic steatosis (HS) is frequently observed in HIV-infected patients. It is not known whether HIV infection is an independent risk factor for HS development. We aimed to analyze whether HIV coinfection was associated ...
Article
Stratification of patients in NASH clinical trials: a pitfall for trial success
(Elsevier, 2020)
Identifying the most effective therapeutic intervention in patients with NAFLD is challenging. Precise stratification in clinical trials is key to ensuring the inclusion of patients who will benefit (and not those who will ...
Article
Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice
(Medycyna Praktyczna, 2020)
Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that encompasses various forms of liver damage not caused by chronic alcohol consumption. In the absence of other etiologies, it ranges from steatosis to ...